Page 63 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 63
low-up of patients discharged from the 72. Busby J, Holweg C, Chai A, et al. Us- 63
hospital following acute asthma: best ing prednisolone and cortisol assays
performed by specialist nurse or doctor? to assess adherence in oral corticoster- the multi-disciplinary team approach to specialist adult difficult asthma care
Chest. 2006 Jul;130(1):51-7. oid dependant asthma: an analysis of
64. Burke H, Davis J, Evans S, et al. A test-retest repeatability. Pulm Phar-
multidisciplinary team case manage- macol Ther 2020 Oct;64:101951. doi:
ment approach reduces the burden of 10.1016/j.pupt.2020.101951.
frequent asthma admissions. ERJ Open
Res. 2016 Jul 29;2(3):00039-2016. doi: 73. Wroe AL. Intentional and unintentional
10.1183/23120541.00039-2016. nonadherence: a study of decision mak-
65. Gamble J, Stevenson M, McClean E, et ing. J Behav Med. 2002 Aug;25(4):355-
al. The prevalence of nonadherence in 72.
difficult asthma. Am J Respir Crit Care
Med. 2009 Nov 1;180(9):817-22. 74. Giraud V, Allaert FA, Roche N. In-
66. Murphy AC, Proeschal A, Brightling haler technique and asthma: feasa-
CE, et al. The relationship between bility and acceptability of training
clinical outcomes and medication ad- by pharmacists. Respir Med. 2011
herence in difficult-to-control asthma. Dec;105(12):1815-22.
Thorax. 2012 Aug;67(8):751-3.
67. Lee J, Tay TR, Radhakrishna N, et al. 75. Mes MA, Katzer CB, Chan AHY, et
Nonadherence in the era of severe asth- al. Pharmacists and medication ad-
ma biologics and thermoplasty. Eur herence in asthma: a systematic re-
Respir J. 2018 Apr 4;51(4):1701836. doi: view and meta-analysis. Eur Respir
10.1183/13993003.01836-2017 J. 2018 Aug 23;52(2):1800485. doi:
68. McNicholl DM, Stevenson M, McGar- 10.1183/13993003.00485-2018.
vey LP, et al. The utility of fractional
exhaled nitric oxide suppression in the 76. Garcia-Cardenas V, Armour C, Ben-
identification of nonadherence in dif- rimoj SI, et al. Pharmacists’ interven-
ficult asthma. Am J Respir Crit Care tions on clinical asthma outcomes: a
Med. 2012 Dec 1;186(11):1102–8. systematic review. Eur Respir J. 2016
69. Heaney LG, Busby J, Bradding P, et al. Apr;47(4):1134-43.
Remotely monitored therapy and nitric
oxide suppression identifies nonadher- 77. Martínez-Rivera C, Crespo A, Pine-
ence in severe asthma. Am J Respir Crit do-Sierra C, et al. Mucus hypersecre-
Care Med. 2019 Feb 15;199(4):454–64. tion in asthma is associated with rhi-
70. Taylor TE, Zigel Y, De Looze C, nosinusitis, polyps and exacerbations.
et al. Advances in audio-based sys- Respir Med. 2018 Feb 1;135:22-28.
tems to monitor patient adherence
and inhaler drug delivery. Chest. 2018 78. Kostikas K, Clemens A, Patalano F.
Mar;153(3):710–22. The asthma-COPD overlap syndrome:
71. Mansur AH, Hassan M, Duffy J, et al. do we really need another syndrome in
Development and clinical application the already complex matrix of airway
of a prednisolone/cortisol assay to de- disease? Int J Chron Obstruct Pulmon
termine adherence to maintenance oral Dis. 2016 Jun 16;11:1297-306.
prednisolone in severe asthma. Chest.
2020 Sep; 158(3):901–12. 79. Mistry H, Ajsivinac Soberanis HM,
Kyyaly MA, et al. The Clinical Impli-
cations of Aspergillus Fumigatus Sen-
sitization in Difficult-To-Treat Asthma
Patients. J Allergy Clin Immunol Pract.
2021 Dec;9(12):4254-67.e10.
80. García-Clemente M, En-
ríquez-Rodríguez AI, Iscar-Urrutia M,
hospital following acute asthma: best ing prednisolone and cortisol assays
performed by specialist nurse or doctor? to assess adherence in oral corticoster- the multi-disciplinary team approach to specialist adult difficult asthma care
Chest. 2006 Jul;130(1):51-7. oid dependant asthma: an analysis of
64. Burke H, Davis J, Evans S, et al. A test-retest repeatability. Pulm Phar-
multidisciplinary team case manage- macol Ther 2020 Oct;64:101951. doi:
ment approach reduces the burden of 10.1016/j.pupt.2020.101951.
frequent asthma admissions. ERJ Open
Res. 2016 Jul 29;2(3):00039-2016. doi: 73. Wroe AL. Intentional and unintentional
10.1183/23120541.00039-2016. nonadherence: a study of decision mak-
65. Gamble J, Stevenson M, McClean E, et ing. J Behav Med. 2002 Aug;25(4):355-
al. The prevalence of nonadherence in 72.
difficult asthma. Am J Respir Crit Care
Med. 2009 Nov 1;180(9):817-22. 74. Giraud V, Allaert FA, Roche N. In-
66. Murphy AC, Proeschal A, Brightling haler technique and asthma: feasa-
CE, et al. The relationship between bility and acceptability of training
clinical outcomes and medication ad- by pharmacists. Respir Med. 2011
herence in difficult-to-control asthma. Dec;105(12):1815-22.
Thorax. 2012 Aug;67(8):751-3.
67. Lee J, Tay TR, Radhakrishna N, et al. 75. Mes MA, Katzer CB, Chan AHY, et
Nonadherence in the era of severe asth- al. Pharmacists and medication ad-
ma biologics and thermoplasty. Eur herence in asthma: a systematic re-
Respir J. 2018 Apr 4;51(4):1701836. doi: view and meta-analysis. Eur Respir
10.1183/13993003.01836-2017 J. 2018 Aug 23;52(2):1800485. doi:
68. McNicholl DM, Stevenson M, McGar- 10.1183/13993003.00485-2018.
vey LP, et al. The utility of fractional
exhaled nitric oxide suppression in the 76. Garcia-Cardenas V, Armour C, Ben-
identification of nonadherence in dif- rimoj SI, et al. Pharmacists’ interven-
ficult asthma. Am J Respir Crit Care tions on clinical asthma outcomes: a
Med. 2012 Dec 1;186(11):1102–8. systematic review. Eur Respir J. 2016
69. Heaney LG, Busby J, Bradding P, et al. Apr;47(4):1134-43.
Remotely monitored therapy and nitric
oxide suppression identifies nonadher- 77. Martínez-Rivera C, Crespo A, Pine-
ence in severe asthma. Am J Respir Crit do-Sierra C, et al. Mucus hypersecre-
Care Med. 2019 Feb 15;199(4):454–64. tion in asthma is associated with rhi-
70. Taylor TE, Zigel Y, De Looze C, nosinusitis, polyps and exacerbations.
et al. Advances in audio-based sys- Respir Med. 2018 Feb 1;135:22-28.
tems to monitor patient adherence
and inhaler drug delivery. Chest. 2018 78. Kostikas K, Clemens A, Patalano F.
Mar;153(3):710–22. The asthma-COPD overlap syndrome:
71. Mansur AH, Hassan M, Duffy J, et al. do we really need another syndrome in
Development and clinical application the already complex matrix of airway
of a prednisolone/cortisol assay to de- disease? Int J Chron Obstruct Pulmon
termine adherence to maintenance oral Dis. 2016 Jun 16;11:1297-306.
prednisolone in severe asthma. Chest.
2020 Sep; 158(3):901–12. 79. Mistry H, Ajsivinac Soberanis HM,
Kyyaly MA, et al. The Clinical Impli-
cations of Aspergillus Fumigatus Sen-
sitization in Difficult-To-Treat Asthma
Patients. J Allergy Clin Immunol Pract.
2021 Dec;9(12):4254-67.e10.
80. García-Clemente M, En-
ríquez-Rodríguez AI, Iscar-Urrutia M,
